英夫利西单抗治疗17例中重度寻常性银屑病

Chinese Journal of Dermatology ›› 2016, Vol. 49 ›› Issue (6): 437-438.

Infliximab for the treatment of 17 cases of moderate to severe psoriasis vulgaris

Received:2015-11-16 Revised:2016-03-03 Online:2016-06-15 Published:2016-05-31

Abstract

References ［6］

［1］	Schön MP, Boehncke WH. Psoriasis［J］. N Engl J Med, 2005, 352（18）: 1899⁃1912. DOI: 10.1056/NEJMra041320.
［2］	Luber AJ, Tsui CL, Heinecke GM, et al. Long⁃term durability and dose escalation patterns in infliximab therapy for psoriasis［J］. J Am Acad Dermatol, 2014, 70（3）: 525⁃532. DOI: 10.1016/j.jaad.2013.10.059.
［3］	Dotan I, Ron Y, Yanai H, et al. Patient factors that increase infli⁃ximab clearance and shorten half⁃life in inflammatory bowel disease: a population pharmacokinetic study［J］. Inflamm Bowel Dis, 2014, 20（12）: 2247⁃2259. DOI: 10.1097/MIB.0000000000000212.
［4］	Gottlieb AB, Evans R, Li S, et al. Infliximab induction therapy for patients with severe plaque⁃type psoriasis: a randomized, double⁃blind, placebo⁃controlled trial［J］. J Am Acad Dermatol, 2004, 51（4）: 534⁃542. DOI: 10.1016/j.jaad.2004.02.021.
［5］	Wetter DA, Davis MD. Lupus⁃like syndrome attributable to anti⁃tumor necrosis factor alpha therapy in 14 patients during an 8-year period at Mayo Clinic［J］. Mayo Clin Proc, 2009, 84（11）: 979⁃984. DOI: 10.4065/84.11.979.
［6］	朱晨雨, 孙秋宁, 舒畅, 等. 英夫利西单抗治疗重度银屑病17例临床观察［J］. 中华皮肤科杂志, 2016, 49（4）: 294⁃295. DOI: 10.3760/cma.j.issn.0412⁃4030.2016.04.021.
	Zhu Chenyu, Sun Qiuning, Shu Chang, et al. Infliximab for the treatment of severe psoriasis in 17 cases: a clinical observational study［J］. Chin J Dermatol, 2016, 49（4）: 294⁃295. DOI: 10.3760/cma.j.issn.0412⁃4030.2016.04.021.

Infliximab for the treatment of 17 cases of moderate to severe psoriasis vulgaris

PDF

Knowledge

Abstract

Cite this article

share this article

References ［6］

Related Articles 0

Metrics

Comments

Recommended 10